Last update 21 Oct 2025

Polycystic ovary syndrome(Celmatix)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
MTNR1A x MTNR1B
Action
agonists
Mechanism
MTNR1A agonists(Melatonin receptor 1A agonists), MTNR1B agonists(Melatonin receptor 1B agonists)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseUrogenital Diseases
Active Indication
Polycystic Ovary Syndrome
Inactive Indication-
Originator Organization
Celmatix, Inc.Celmatix, Inc.Aché Laboratórios Farmacêuticos SAAché Laboratórios Farmacêuticos SA
Active Organization
Aché Laboratórios Farmacêuticos SAAché Laboratórios Farmacêuticos SACelmatix, Inc.Celmatix, Inc.
Inactive Organization-
License Organization
Celmatix, Inc.Celmatix, Inc.Aché Laboratórios Farmacêuticos SAAché Laboratórios Farmacêuticos SA
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

3
Clinical Trials associated with Polycystic ovary syndrome(Celmatix)
ChiCTR2400094991
/ Not yet recruitingNot ApplicableIIT
Study on the protocol and related mechanism of combined pretreatment of GnRHa and letrozole to improve clinical outcomes in infertile patients with ovarian chocolate cysts before IVF
ChiCTR2400084006
/ Not yet recruitingNot ApplicableIIT
To investigate the effect of Zishenyutai pill on IVF-ET outcome in patients with polycystic ovary syndrome (PCOS) based on NLRP3 inflammasome
ChiCTR2300073832
/ Not yet recruitingNot ApplicableIIT
Prospective cohort study on polycystic ovary syndrome (pcos) by "tonifying kidney, removing blood stasis and dredging collaterals"
100 Clinical Results associated with Polycystic ovary syndrome(Celmatix)
Login to view more data
100 Translational Medicine associated with Polycystic ovary syndrome(Celmatix)
Login to view more data
100 Patents (Medical) associated with Polycystic ovary syndrome(Celmatix)
Login to view more data
100 Deals associated with Polycystic ovary syndrome(Celmatix)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Polycystic Ovary SyndromePreclinical
United States
Celmatix, Inc.Celmatix, Inc.
08 Aug 2023
Polycystic Ovary SyndromePreclinical
Brazil
Aché Laboratórios Farmacêuticos SAAché Laboratórios Farmacêuticos SA
08 Aug 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free